These compounds may interact with:
Somatostatin receptor type 3
Potentially involved in: carcinoma; adenoma; pituitary adenoma; acromegaly; cancer; pancreatic neoplasm; status epilepticus; neuroendocrine tumors; mood disorders; osteosarcoma; ovarian cancer; psoriasis; pancreatic neoplasms; hypercortisolism; diarrhea from pancreatic vipoma; carcinoid syndrome
Disease data sourced from Pharos.